At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 579 enrolled
Drug / intervention
atorvastatin +2 moredrug
Likely dose
atorvastatin 80 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Rand., Double-Blind, Titration Study to Evaluate & Compare the Efficacy & Safety of Ezetimibe Plus Atorvastatin Vs Atorvastatin in Hypercholesterolemic Pts. at High Risk for CHD Not Adequately Controlled on Atorvastatin 40 Mg
In Brief
A Phase 3 clinical trial evaluating atorvastatin and ezetimibe for Hypercholesterolemia. Completed, enrolled 579 participants.
Detailed Summary
To Evaluate and Compare the Efficacy and Safety of Ezetimibe Plus Atorvastatin Versus Atorvastatin in Hypercholesterolemic Patients at High Risk for Coronary Heart Disease Not Adequately Controlled on Atorvastatin 40 mg.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypercholesterolemia
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 2006
Enrollment StartFeb 2006
Primary CompletionFeb 2008
Study CompletionMar 2008
TodayJul 2026
First PostedJan 13, 2006
Enrollment StartFeb 1, 2006
Primary CompletionFeb 1, 2008
Study CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 20.5 years ago
Interventions
atorvastatindrug
Atorvastatin 80 mg tablet by mouth, once a day for 6 weeks
atorvastatindrug
Atorvastatin 40 mg by mouth, once a day for 6 weeks
ezetimibedrug
Ezetimibe 10 mg tablets by mouth, once a day for 6 weeks.